| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/26/2011 | DE102009047013A1 Cooking device for use in household appliance i.e. baking oven, for cooking barbeque goods, has sensor unit determining condition of cooking goods using sensor elements, which are fixed at goods carrier elements in operating condition |
| 05/26/2011 | CA2818514A1 Bioreactors, systems, and methods for producing and/or analyzing organs |
| 05/26/2011 | CA2817671A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | CA2809068A1 Device for detecting analyte in sample |
| 05/26/2011 | CA2807284A1 Grey water diversion system |
| 05/26/2011 | CA2781754A1 Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker |
| 05/26/2011 | CA2781556A1 Method and apparatus for performing assays |
| 05/26/2011 | CA2781549A1 Normalization of platelet biomarkers |
| 05/26/2011 | CA2781465A1 Methods for optimizing petroleum reservoir analysis |
| 05/26/2011 | CA2781408A1 Biomarkers of cancer |
| 05/26/2011 | CA2781371A1 Assays for human nt-pro b-type natriuretic peptide, human pro b-type natriuretic peptide and human b-type natriuretic peptide |
| 05/26/2011 | CA2781277A1 Urinary triaosylceramide (gb3) as a marker of cardiac disease |
| 05/26/2011 | CA2781270A1 Chemical-selective device |
| 05/26/2011 | CA2781255A1 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| 05/26/2011 | CA2781248A1 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | CA2781181A1 New medical methods and agents for use therein |
| 05/26/2011 | CA2781153A1 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions |
| 05/26/2011 | CA2781151A1 Reducing leukocyte interference in competitive immunoassays |
| 05/26/2011 | CA2781150A1 Reducing leukocyte interference in non-competitive immunoassays |
| 05/26/2011 | CA2781117A1 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | CA2781110A1 Peptides and methods for the detection of lyme disease antibodies |
| 05/26/2011 | CA2781044A1 Predictive markers for taxane responsiveness and methods of use thereof |
| 05/26/2011 | CA2781019A1 Display of disulfide linked dimeric proteins on filamentous phage |
| 05/26/2011 | CA2780932A1 Assay for quantifying clostridial neurotoxin |
| 05/26/2011 | CA2780807A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | CA2780648A1 Organic colored microparticles, diagnostic reagent kit containing the same, and in vitro diagnosis method |
| 05/26/2011 | CA2778705A1 Methods for improving the design, bioavailability, and efficacy of directed sequence polymer compositions via serum protein-based detection of directed sequence polymer compositions |
| 05/26/2011 | CA2777650A1 Electrophoretic analysis method |
| 05/26/2011 | CA2776751A1 Methods to predict clinical outcome of cancer |
| 05/25/2011 | EP2325652A2 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 05/25/2011 | EP2325651A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 05/25/2011 | EP2325649A1 Dye-assisted laser desorption ionization (DALDI) |
| 05/25/2011 | EP2325648A1 Cancer detection method |
| 05/25/2011 | EP2325647A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XX |
| 05/25/2011 | EP2325646A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XVII |
| 05/25/2011 | EP2325645A2 Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiii |
| 05/25/2011 | EP2325644A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XII |
| 05/25/2011 | EP2325643A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XV |
| 05/25/2011 | EP2325642A1 Use of multimodality nanostructures to detect target substances |
| 05/25/2011 | EP2325641A1 Biological indicator |
| 05/25/2011 | EP2325640A1 Test apparatus for membrane assay equipped with reference display section |
| 05/25/2011 | EP2325639A1 Cystatin c adsorption inhibitor |
| 05/25/2011 | EP2325638A1 Method for high recovery of serum low-abundance, low molecular-weight proteins and their analysis by matrix assisted laser desorption ionization mass spectrometry |
| 05/25/2011 | EP2325637A1 Novel Rab binding partners of Myosin Va |
| 05/25/2011 | EP2325636A1 Method for fluid clotting time determination |
| 05/25/2011 | EP2325635A2 Sensor chip, sensor cartridge, and analysis apparatus |
| 05/25/2011 | EP2325634A2 Sensor chip, sensor cartridge, and analysis apparatus |
| 05/25/2011 | EP2325633A2 Dissolution test vessel with integral centering |
| 05/25/2011 | EP2325631A1 Antibody conjugated to peptide via a UV cleavable linker |
| 05/25/2011 | EP2325629A1 Method for quality assurance of a biosensor test strip |
| 05/25/2011 | EP2325622A1 Optical-based sensing device |
| 05/25/2011 | EP2325619A1 Sample collecting implement |
| 05/25/2011 | EP2325338A2 Markers for detection of gastric cancer |
| 05/25/2011 | EP2325336A1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 05/25/2011 | EP2325327A1 Method for evaluating specific incorporation of d-glucose into cells |
| 05/25/2011 | EP2325325A1 Methods for the reduction of stutter in microsatellite amplification |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
| 05/25/2011 | EP2325310A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
| 05/25/2011 | EP2325302A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
| 05/25/2011 | EP2325301A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
| 05/25/2011 | EP2325294A2 Visual-servoing optical microscopy |
| 05/25/2011 | EP2325263A1 Modified carbocyanine dyes and their conjugates |
| 05/25/2011 | EP2325209A2 Improved protofibril selective antibodies and the use thereof |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2324855A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324767A1 Process for producing an electrochemical biosensor |
| 05/25/2011 | EP2324361A1 Novel method of prognosis associated with cases of postpartum haemorrhage |
| 05/25/2011 | EP2324360A2 Biomarker detection process and assay of neurological condition |
| 05/25/2011 | EP2324359A1 Monoclonal antibody stro-4 |
| 05/25/2011 | EP2324358A1 Monitoring anti-angiogenesis therapy |
| 05/25/2011 | EP2324357A1 Kit useful for detecting, separating and/or characterizing a molecule of interest |
| 05/25/2011 | EP2324355A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/25/2011 | EP2324354A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/25/2011 | EP2324353A1 Selectively functionized transducer microarray |
| 05/25/2011 | EP2324352A2 Method and apparatus for the discretization and manipulation of sample volumes |
| 05/25/2011 | EP2324351A1 Non-hypergeometric overlap probability |
| 05/25/2011 | EP2324350A1 Reference control for cell by cell analysis |
| 05/25/2011 | EP2324349A1 Method for capturing measurement values and displaying measurement values |
| 05/25/2011 | EP2324344A2 Improved capacitive sensor and method for making the same |
| 05/25/2011 | EP2324333A2 Porous materials for biological sample collection |
| 05/25/2011 | EP2324127A2 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity |
| 05/25/2011 | EP2324111A2 Peripheral zone tumor cells, methods for their preparation and use |
| 05/25/2011 | EP2324063A2 Non-invasive fetal rhd genotyping from maternal whole blood |
| 05/25/2011 | EP2324052A1 Marker of streptococcus anginosus / streptococcus constellatus (moac) and uses thereof |
| 05/25/2011 | EP2323996A1 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| 05/25/2011 | EP2323764A1 Apparatus and methods for effecting chemical assays |
| 05/25/2011 | EP2323687A2 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/25/2011 | EP2323681A2 Methods for treating viral disorders |
| 05/25/2011 | EP2323475A1 High fructan cereal plants |
| 05/25/2011 | EP2240786B1 Reaction cuvette supply to an automatic analysis machine |
| 05/25/2011 | EP2089688B1 A device and a method for sampling of milk |
| 05/25/2011 | EP1979363B1 Novel silane compounds and use thereof in order to functionalise solid media and immobilise biological molecules on said media |
| 05/25/2011 | EP1978867B1 Methods for characterizing tissues |
| 05/25/2011 | EP1973937B1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 05/25/2011 | EP1904657B1 METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |